Information Technology · Services-Help Supply Services

TBI TrueBlue, Inc. SEC Filings & Insider Trading Activity 2026

company
CIK 768899119 filings
Russell 2000

TBI at a glance

TrueBlue, Inc. (TBI, SEC CIK 768899) filed its latest 10-K annual report on February 18, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 4, 2026 and Form 4 insider filings as recently as November 20, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 28, 2025 (FY2025), TrueBlue, Inc. (TBI) reported revenue of $1.6 billion (up 3.1% from FY2024) and a net loss of $48.0 million. Diluted EPS was -$1.61.
  • As of September 30, 2026, 29 institutional investment managers tracked by SignalX reported holding TrueBlue, Inc. (TBI) shares worth $91.1 million in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by Ferencz Garrett on November 12, 2026 of 600 shares at $12.34 per share.
  • In the last 90 days, TBI insiders reported 0 open-market purchases ($0) and 3 open-market sales ($177K) on Form 4, a net sale of $177K.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$1.6B
+3.1% vs prior year
Insiders · 90 days
0 buys · 3 sells
Net −$177K
13F holders
29 funds
$91.1M · +2 vs prior quarter
Latest 8-K
Nov 4, 2026
Item 2.02 · Item 7.01

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 27, 2026

Risk Factors

  • Newly updated governance risk: unsolicited proposals to buy all or part of TrueBlue triggered expanded takeover-related disclosures
  • Most material legal risk: Washington law and shareholder-rights provisions may delay or prevent a change of control
  • Operational risk: one client represents over 10% of consolidated revenue, creating concentration exposure
  • Market risk: acquisition proposals and activist campaigns could increase stock-price volatility
  • Financial risk: slower collection from concentrated receivables could weaken cash flows

Management Discussion & Analysis

  • Q3 revenue $520.7M, up 20.7% YoY from $431.3M
  • Gross margin 20.5% vs 22.7% YoY; operating margin 2.3% vs approximately 0% YoY
  • Best segment PeopleReady: revenue $338.0M, up 34.4%; segment margin 5.9% vs 3.2%
  • Cash $19.8M, debt $102.3M, unused borrowing capacity $66.5M
  • Operating cash flow used $56.4M; no share repurchases, $33.5M authorization remaining
  • Headwinds: lower-margin energy mix, higher workers’ compensation costs, stabilizing OnSite and healthcare demand

AI summary of the TBI 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 4, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q3 FY2026 results for quarter ended September 27, 2026, with Q4 and full-year outlook
  • Management conference call scheduled November 4, 2026, at 2:00 p.m. Pacific Time

Item 7.01: Regulation FD Disclosure

  • Investor roadshow presentation attached as Exhibit 99.3
  • Presentation intended for Q3 2026 earnings discussion and future investor conferences

Item EX-99.3: Item EX-99.3

  • Investor roadshow outlines growth strategy across staffing and global RPO, emphasizing market expansion, sales execution, digital transformation and efficiency
  • 2025 revenue $1.6B, with 10M+ people connected to work and 3M+ clients served

Item EX-99.2: Item EX-99.2

  • Q3 2026 revenue $521M, up 21%, led by PeopleReady revenue growth of 34% to $338M
  • GAAP net income $9.2M, or $0.28 per share, versus a $1.9M loss in Q3 2025

Item EX-99.1: Item EX-99.1

  • Q3 revenue $521 million, up 21%, marking the fifth consecutive quarter of top-line growth
  • Net income $9 million, or $0.28 per share, versus a $2 million loss and $0.06 loss per share
Filed Oct 26, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Elizabeth Castro Gulacsy appointed independent director effective October 26, 2026
  • Former United Parks & Resorts CFO adds public-company finance and cost-discipline expertise

Item 8.01: Other Events

  • TrueBlue appointed Ms. Castro Gulacsy, making leadership composition the primary investor-relevant development
  • Appointment details, including role and responsibilities, are provided in Exhibit 99.1

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • Elizabeth Castro Gulacsy appointed director effective October 26, 2026, expanding the Board to ten members
  • Audit Committee appointment adds public-company finance, accounting, debt refinancing, and risk-management expertise
Filed Aug 4, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q2 fiscal 2026 results cover the period ended June 28, 2026
  • Third-quarter and fiscal-year 2026 outlook included in Exhibit 99.1

Item 7.01: Regulation FD Disclosure

  • Investor Roadshow Presentation attached as Exhibit 99.3 for Q2 2026 earnings discussion and future conferences
  • Presentation available on TrueBlue’s website, expanding investor access to management’s messaging

Item EX-99.3: Item EX-99.3

  • Investor roadshow highlights $1.6B 2025 revenue, $133M share repurchases, and 10M+ people connected with work
  • Staffing portfolio spans PeopleReady, PeopleManagement, and PeopleSolutions, with 2025 revenue shares of 55%, 34%, and 11%

Item EX-99.1: Item EX-99.1

  • Q2 revenue $443 million, up 12%, signaling renewed growth across skilled verticals and core on-demand staffing
  • Adjusted EBITDA $11 million, up from $3 million, with margin improving to 2.6% from 0.7%

Item EX-99.2: Item EX-99.2

  • Q2 revenue $443M, up 12%, led by skilled businesses and renewed growth in core on-demand staffing
  • GAAP net loss widened to $3.4M from $0.2M, including a $3M non-cash loss on held-for-sale assets

AI summaries of TBI 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for TBI

Don't miss the next TBI filing

  • Alerts as it files. A push when TBI files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut TBI, by share count.
  • Ask anything. An AI agent that reads every TBI filing and answers with sources.

TBI alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Ferencz GarrettJNov 18, 2026$11.90
Ferencz GarrettSellNov 12, 2026$12.34
Ferencz GarrettSellNov 10, 2026$12.26
Ferencz GarrettSellNov 9, 2026$11.90
Gulacsy ElizabethANov 2, 2026-
Schweihs CarlFNov 1, 2026$9.77
Owen Taryn RFOct 3, 2026$9.18
Owen Taryn RFOct 2, 2026$9.18

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$1.6B$1.6B
Gross Profit-$406.4M$367.8M
Operating Income--$92.8M-$46.6M
Net Income--$125.7M-$48.0M
Gross Margin-25.9%22.8%
Op. Margin--5.9%-2.9%
Net Margin--8.0%-3.0%
Balance Sheet
Total Assets$899.4M$675.4M$638.7M
Equity$457.9M$315.4M$274.6M
ROE--39.9%-17.5%
Per Share
EPS-$-4.17$-1.61
Cash Flow
Operating CF--$17.1M-$58.0M
CapEx-$24.2M$15.7M

Source: XBRL data in TrueBlue, Inc. (TBI)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate TBI share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
TBI shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202629$91.1M
Q2 202627$64.9M
Q1 202628$33.6M
Q4 202525$49.7M
Q3 202525$69.8M
Q2 202525$74.7M
Q1 202522$59.2M
Q4 202419$92.7M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 200 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

TBI filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 20, 2026--
4Nov 16, 2026--
4Nov 12, 2026--
8-KNov 4, 2026Analysis-
10-QNov 4, 2026Analysis
4Nov 3, 2026--
4Nov 3, 2026--
8-KOct 26, 2026Analysis-
4Oct 6, 2026--
10-QAug 4, 2026Analysis
8-KAug 4, 2026Analysis-
4Jun 8, 2026-
8-KMay 15, 2026Analysis
8-KMay 6, 2026Analysis
8-KMay 5, 2026Analysis-
10-QMay 5, 2026Analysis
8-KApr 13, 2026Analysis-
4Apr 7, 2026--
4Feb 26, 2026--
4Feb 26, 2026--
4Feb 25, 2026--
4Feb 25, 2026--
4Feb 25, 2026--
4Feb 25, 2026--
4Feb 24, 2026--

Related Information Technology companies

All Information Technology →

TBI SEC filings: frequently asked questions

Are TBI insiders buying or selling?

In the last 90 days, TrueBlue, Inc. (TBI) officers, directors and 10% owners reported no open-market purchases and 3 open-market sales worth $177,415 by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold TBI stock?

As of September 30, 2026, the largest TrueBlue, Inc. (TBI) holders among the 13F filers tracked by SignalX were BlackRock ($20.6 million), Vanguard Capital Management LLC ($11.2 million), IES Holdings, Inc. ($9.9 million), D.E. Shaw & Co ($6.7 million), State Street Corp ($6.0 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was TBI's revenue in fiscal year 2025?

For the fiscal year ended December 28, 2025 (FY2025), TrueBlue, Inc. (TBI) reported revenue of $1.6 billion (up 3.1% from FY2024) and a net loss of $48.0 million. Diluted EPS was -$1.61. The figures come from the XBRL data in the 10-K.

What did TBI report in its latest 8-K?

TrueBlue, Inc. (TBI) filed an 8-K on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). Q3 FY2026 results for quarter ended September 27, 2026, with Q4 and full-year outlook.

What are the latest TBI SEC filings?

TrueBlue, Inc. (TBI) filed its latest 10-K annual report on February 18, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 4, 2026 and a Form 4 insider filing on November 20, 2026.

What is TBI's SEC CIK number?

TrueBlue, Inc. (TBI)'s SEC Central Index Key (CIK) is 768899. EDGAR lists every TBI filing under that number.

Ask anything about TBI

The research agent reads TBI's filings, financials, insider trades and 13F holders, then answers with sources.